StockData
iBio, Inc. logo

iBio, Inc. (IBIO) KPIs and segments

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive iBio's business

iBio's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

iBio's fiscal year ends June 30 — Q4 FY26 = CQ2 2026 (calendar quarter).

Periods
Add to chartMetric
Q4 FY26
Q3 FY26
Q2 FY26
Q4 FY25
Q3 FY25
Q2 FY25
Q4 FY22
Q3 FY22
Q2 FY22
Q4 FY21
Q3 FY21
Q2 FY21
Earlier reporting (last reported 2022)2
Earlier reporting (last reported 2026)1
Earlier reporting (last reported 2022)2
Earlier reporting (last reported 2022)2
Earlier reporting (last reported 2022)2

3 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-28.

See a number that looks wrong?